Coalescence Partners
Institutional investorNew York · Seed · 9 people tracked
Also known as COALESCENCE PARTNERS INVESTMENT MANAGEMENT LP
Find your way into Coalescence Partners
Sign up to see every warm intro you have to Coalescence Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Coalescence Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The firm rejects intuition-based decision-making in favor of a strict framework grounded in fact and logic, stripping away opinion and emotion. It holds that good companies require time to prove their value, while short-term prices are influenced by non-fundamental factors, creating opportunities for fundamental investors with long-term horizons. Valuation is treated as useful only when paired with genuine understanding of fundamentals, and in-depth fundamental analysis is viewed as the best form of risk control. The firm stresses balancing conviction with flexibility—staying confident in fact-based judgements while respecting personal limitations and the unpredictability of market conditions.
Source: firm website, verified Oct 13, 2026.
Team · 9 people
from the firm's websiteManaging partner and portfolio manager of the firm's public equity investments and an investment committee member for the New Hope-Coalescence private equity investments, with 17 years of global investment experience. Previously managed global equities portfolios at Northern Cross and Institutional Capital. Holds a BE from Tianjin University, an MS from the Singapore-MIT Alliance, and an MBA from the University of Chicago.
Partner and co-founder with 20 years of experience in investment, strategy, and operations, responsible for clients' US private equity and venture investments. Previously co-founder and COO of Ray Shi Capital and VP of Greater China at Vision Capital Advisors, and worked at PepsiCo and the Boston Consulting Group. Holds a BA in applied math from Harvard University.
An investment associate on the New Hope-Coalescence private equity team. Previously a financial analyst at Houlihan Lokey and an analyst at Towers Watson. Holds economics and mathematics degrees from Wuhan University and an MS in financial engineering from UC Berkeley's Haas School of Business.
An investment analyst on the public equity team who joined after graduating from the University of Chicago. Interned at World Business Chicago and the Israeli Parliament's research center, and helped found education tech startup HexinEdu. Holds a BS in life science from Tsinghua University and a Master of Public Policy from the University of Chicago.
An investment analyst on the New Hope-Coalescence private equity team. Previously a structured finance rating analyst at United Credit Ratings and a financial analyst at Lead Ocean. Holds a BS in chemistry and a master of finance from Purdue University.
An analyst on the operations team who joined after graduating from the University of Southern California. Interned at Ruihua Certified Public Accountants and volunteered with the IRS VITA program. Holds BBA and accounting degrees from USC.
An investment analyst on the public equity team. Previously an equity analyst at Fountainhead Partners and at Franchise Capital, and began her career as an associate at Tsinghua Holdings Capital, covering healthcare, advanced manufacturing, and consumer goods. Holds a physics degree from Nanjing University and studied in a PhD program at Cambridge.
A controller on the operations team. Previously controller at Yulan Capital Management and a fund accountant at Chilton Investment Company, and started his career on Blackstone's Hedge Fund Solutions (BAAM) operations team. Holds a BBA in accounting from Baruch College and an MS in taxation from Pace University.
A senior investment analyst on the public equity team covering TMT. Previously a senior analyst at Perseverance Asset Management and first product architect for Baidu's mobile app, and interned at Microsoft's Asia Pacific R&D group. Holds a master's in pattern recognition from Beijing University of Posts and Telecommunications.
Frequently asked questions
- What stage does Coalescence Partners invest at?
- Coalescence Partners invests at the Seed stage.
- What sectors does Coalescence Partners focus on?
- Coalescence Partners focuses on Advanced Manufacturing, AI & Machine Learning, Consumer, Healthtech, Media & Entertainment.
- Where is Coalescence Partners located?
- Coalescence Partners is headquartered in New York, US.
Similar investors
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
Kalaari Capital is an India-focused early-stage venture capital firm that backs founders building technology companies across sectors including deeptech, space, AI, cloud, consumer internet, fintech and healthcare.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kibo Ventures is a Spanish venture capital firm that backs startups, having served as an early and long-term institutional investor to companies across Spain and Europe.
Samsung Next is the venture investing arm associated with Samsung that backs ambitious founders across AI, healthtech, consumer services, and frontier technology.

